LIFE QUALITY OF HEPATITIS C PATIENTS
Kanza Ijaz, Omer B., Mehmood K.T.
1 Lahore College for Women University, Jail Road, Lahore, Pakistan. 2 Lahore College for Women University, Jail Road, Lahore, Pakistan. 3 Drug Testing Lab, BirdWood Road, Lahore, Pakistan.
Keywords: Hepatitis C, liver, quality of life
Abstract

Hepatitis is a disease characterized by inflammation of the liver, usually producing swelling and damage to liver tissues. The hepatitis C virus causes hepatitis C. A marked reduction in the quality of life of hepatitis C patients has been revealed in a number of studies conducted worldwide. A retrospective study was carried out among hundred patients of hepatitis C and three of them were followed for a period of 3months. The major aims of this study were to evaluate the quality of life of the patients suffering from hepatitis C, estimation of the patient compliance with the management methods, evaluation of the end results of the therapeutic treatment, assessment of the patient satisfaction with the medicines, comparison of the quality of life of the suffering patients with their optimum health state and the comparison of the quality of life of the patients during and after the management/treatment of the disease. In order to follow the study, a medication history/patient interview form was developed on the basis of which patients suffering from hepatitis C were interviewed. This survey was followed by the comparison of national treatment guidelines with international treatment guidelines. The study revealed that the patients were not satisfied with their quality of life during their ailment whereas many expressed that their quality of life improved after receiving a rational and well managed medical treatment.

Article Information

Identifiers and Pagination:
Year:2012
Volume:4
First Page:56
Last Page:63
Publisher Id:JAppPharm (2012 ). 4. 56-63
Article History:
Received:November 1, 2011
Accepted:December 18, 2011
Collection year:2011
First Published:January 11, 2012


© 2016 The Author(s). This open access article is distributed under a Creative Commons Attribution (CC-BY) 4.0 license. You are free to: Share — copy and redistribute the material in any medium or format Adapt — remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms: Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. No additional restrictions You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits
Editor in Chief
Prof. Dr. Cornelia M. Keck (Philipps-Universität Marburg)
Marburg, Germany

Bibliography

Welcome to the research group of Prof. Dr. Cornelia M. Keck in Marburg. Cornelia M. Keck is a pharmacist and obtained her PhD in 2006 from the Freie Universität (FU) in Berlin. In 2009 she was appointed as Adjunct Professor for Pharmaceutical and Nutritional Nanotechnology at the University Putra Malaysia (UPM) and in 2011 she obtained her Venia legendi (Habilitation) at the Freie Universität Berlin and was appointed as a Professor for Pharmacology and Pharmaceutics at the University of Applied Sciences Kaiserslautern. Since 2016 she is Professor of Pharmaceutics and Biopharmaceutics at the Philipps-Universität Marburg. Her field of research is the development and characterization of innovative nanocarriers for improved delivery of poorly soluble actives for healthcare and cosmetics. Prof. Keck is executive board member of the German Association of Nanotechnology (Deutscher Verband Nanotechnologie), Vize-chairman of the unit „Dermocosmetics“ at the German Society of Dermopharmacy, active member in many pharmaceutical societies and member of the BfR Committee for Cosmetics at the Federal Institute for Risk Assessment (BfR).

Journal Highlights
Abbreviation: J App Pharm
doi: http://dx.doi.org/10.21065/19204159
Frequency: Annual 
Current Volume: 9 (2017)
Next scheduled volume: December, 2018 (Volume 10)
Back volumes: 1-9
Starting year: 2009
Nature: Online 
Submission: Online  
Language: English

Subject & Scope
  • Pharmaceutics
  • Physical Pharmacy 
  • Dosage Forms Science 
  • Pharmaceutical Microbiology & Immunology 
  • Industrial Pharmacy 
  • Bio-Pharmaceutics 
  • Pharmaceutical Chemistry 
  • Pharmaceutical Instrumentation 
  • Medicinal Chemistry 
  • Pharmacognosy 
  • Physiology &Histology 
  • Anatomy & Pathology 
  • Pharmacology & Therapeutics 
  • Pharmacy Practice 
  • Pharmaceutical Mathematics   
  • Biostatistics 
  • Dispensing 
  • Community Social & Administrative Pharmacy 
  • Hospital Pharmacy 
  • Clinical Pharmacy 
  • Pharmaceutical Quality Management 
  • Forensic Pharmacy 
  • Pharmaceutical Technology 
  • Pharmaceutical Management & Marketing

Consortium Publisher is an online publisher that enjoys global presence with International Journals

Follow Us

©2009 - 2019 Consortium Publisher Canada

Contact Info

6252 Lisgar Dr Mississauga Ontario L5N7V2 Canada
+1 (647) 526-0885
office@consortiumpublisher.ca
http://www.consortiumpublisher.ca/